Ochang site, located in Ochang-eup, Chungcheongbuk-do, is proud to present its fully integrated Filling and Finishing facility, the W&FF(Warehousing and Filling and Finishing). W&FF facility was newly built in 2019 for the purpose of handling all DP operations from filling, packaging to distributing. W&FF has an isolator filling line, a safest method known in manufacturing sterile vial products, as well as a quality packaging line with automatic visual inspection, 100% IPC CCIT and foreign body detection. Its warehouse runs on a fully automated barcoding system, along with WMS(Warehouse Management System) to ensure effective and structural operation on all floors. W&FF is currently able to manufacture deactivated vaccine, protein recombinant and mRNA based products.
Hwasun site, located in Hwasun, Jeollanam-do, is GC Biopharma’s leading vaccine manufacturing site. Hwasun site is known for its WHO approved facility and its pre-WHO approved GC Flu(Quadrivalent Influenza vaccine). Hwasun site manufactures both live attenuated and deactivated vaccines in vials and PFS and is equipped with O-RABS filling line, automated visual inspection and labeling and secondary packaging line.
GC Biopharma is offering contract manufacturing (CMO) for vaccines, sterile filled vials and PFS. With over 50 years’ experience in the production of biopharmaceuticals, GC Biopharma is surely your best one-stop-solution to fill finish! For more information, check out our Fill Finish Brochure or contact the Sales Team.(gcpharmacmo@gccorp.com)